RESPIBIOME Trademark

Trademark Overview


On Friday, February 15, 2019, a trademark application was filed for RESPIBIOME with the United States Patent and Trademark Office. The USPTO has given the RESPIBIOME trademark a serial number of 79254543. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2019. This trademark is owned by Lallemand Pharma AG. The RESPIBIOME trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for oral, nasal, and topical applications in the form of sprays for the prevention and treatment of pathogenic biofilm derived infections; medicinal preparations for the mouth and as sprays; decongestant nasal sprays
respibiome

General Information


Serial Number79254543
Word MarkRESPIBIOME
Filing DateFriday, February 15, 2019
Status700 - REGISTERED
Status DateTuesday, October 8, 2019
Registration Number5876843
Registration DateTuesday, October 8, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements


Goods and ServicesMedicinal preparations for oral, nasal, and topical applications in the form of sprays for the prevention and treatment of pathogenic biofilm derived infections; medicinal preparations for the mouth and as sprays; decongestant nasal sprays

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLallemand Pharma AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameLallemand Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameLallemand Pharma AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, February 21, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 4, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, February 4, 2020FINAL DISPOSITION PROCESSED
Wednesday, January 8, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 8, 2019REFUSAL PROCESSED BY IB
Friday, June 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 21, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 21, 2019REFUSAL PROCESSED BY MPU
Sunday, April 28, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, April 27, 2019NON-FINAL ACTION WRITTEN
Friday, April 26, 2019ASSIGNED TO EXAMINER
Friday, April 19, 2019NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, April 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 29, 2019APPLICATION FILING RECEIPT MAILED
Monday, March 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 21, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB